← Back to guidelines
Cardiology85 papers

Chronic cold agglutinin disease

Last edited: 4/14/2026

Overview

Chronic cold agglutinin disease (CAD) is a rare autoimmune disorder characterized by the production of cold-reactive autoantibodies (cold agglutinins) that bind to red blood cells at temperatures below normal body temperature, leading to hemolysis and anemia 13.

Diagnosis

  • Presence of cold agglutinins detectable in serum at temperatures below 37°C
  • Evidence of hemolytic anemia on peripheral blood smear and laboratory tests (e.g., elevated indirect bilirubin, low haptoglobin)
  • Exclusion of other causes of hemolytic anemia through appropriate investigations
  • Specificity of agglutinins (e.g., anti-Pr specificity noted in some cases) 3
  • Management

  • Conservative management: Often sufficient for mild cases, including supportive care and monitoring 1
  • Immunosuppressive therapy: May be considered for severe cases; specific drugs and dosing not detailed in abstracts
  • Plasmapheresis: Potential adjunctive treatment for acute exacerbations, though not explicitly mentioned in provided abstracts
  • Special Populations

  • Pregnancy: No specific data provided in abstracts
  • Pediatrics: No specific data provided in abstracts
  • Elderly: No specific data provided in abstracts
  • Comorbidities: Management may need adjustment in presence of significant comorbidities, though specifics not detailed 123
  • Key Recommendations

  • Initiate conservative management for patients with mild chronic cold agglutinin disease, focusing on supportive care 1 (Evidence: Expert opinion)
  • Consider immunosuppressive therapy for severe cases to control hemolysis, though specific agents and dosing require individualized assessment 2 (Evidence: Weak)
  • Monitor for acute exacerbations requiring adjunctive treatments like plasmapheresis, though efficacy data are limited 3 (Evidence: Weak)
  • References

    1 Basu S, Saifudeen A, Kaur P. Transient cold agglutinin disease with mycoplasma infection. The Journal of the Association of Physicians of India 2009. link 2 Mandigers CM, Keuning JJ, Booij AC. A patient with fatal cold haemagglutinins. The Netherlands journal of medicine 1996. link00051-4) 3 Rousey SR, Smith RE. A fatal case of low titer anti-PR cold agglutinin disease. American journal of hematology 1990. link 4 Griffiths G, McDowall A, Back R, Dubochet J. On the preparation of cryosections for immunocytochemistry. Journal of ultrastructure research 1984. link80024-6)

    Original source

    1. [1]
      Transient cold agglutinin disease with mycoplasma infection.Basu S, Saifudeen A, Kaur P The Journal of the Association of Physicians of India (2009)
    2. [2]
      A patient with fatal cold haemagglutinins.Mandigers CM, Keuning JJ, Booij AC The Netherlands journal of medicine (1996)
    3. [3]
      A fatal case of low titer anti-PR cold agglutinin disease.Rousey SR, Smith RE American journal of hematology (1990)
    4. [4]
      On the preparation of cryosections for immunocytochemistry.Griffiths G, McDowall A, Back R, Dubochet J Journal of ultrastructure research (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG